LoginRegister
    Roche wins US antitrust nod for USD 4.3 billion deal to buy Spark TherapeuticsRoche wins US antitrust nod for USD 4.3 billion deal to buy Spark Therapeutics
    Axsome Therapeutics depression drug AXS-05 meets goal in late-stage trialAxsome Therapeutics depression drug AXS-05 meets goal in late-stage trial
    Glenmark Baddi unit gets GMP certificate from State Institute for Drug ControlGlenmark Baddi unit gets GMP certificate from State Institute for Drug Control
    Issue of Corruption in CDSCO raised in Parliament; DetailsIssue of Corruption in CDSCO raised in Parliament; Details
    Amarin fish-oil drug Vascepa gets USFDA nod for cutting cardiac risksAmarin fish-oil drug Vascepa gets USFDA nod for cutting cardiac risks
    Horizon Therapeutics thyroid eye disease drug Teprotumumab gets USFDA panel votesHorizon Therapeutics thyroid eye disease drug Teprotumumab gets USFDA panel votes
    Abbott CEO Miles D White to step down in 2020, Robert B Ford to take overAbbott CEO Miles D White to step down in 2020, Robert B Ford to take over
    Sackler-owned opioid maker pushes overdose treatment abroadSackler-owned opioid maker pushes overdose treatment abroad
    CDSCO to set up Public Relations Offices at all Zonal, Sub-Zonal Offices for regulator guidanceCDSCO to set up Public Relations Offices at all Zonal, Sub-Zonal Offices for regulator guidance
    Pfizer gets USFDA nod for Xeljanz XR Extended-Release Tablets to treat Ulcerative ColitisPfizer gets USFDA nod for Xeljanz XR Extended-Release Tablets to treat Ulcerative Colitis
    GSK seeks marketing licence for baby-friendly HIV pill DolutegravirGSK seeks marketing licence for baby-friendly HIV pill Dolutegravir
    Alkermes gets USFDA warning letter for misleading Vivitrol adsAlkermes gets USFDA warning letter for misleading Vivitrol ads
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X